Literature DB >> 9563729

Safety of inducing sputum in patients with asthma of varying severity.

P T de la Fuente1, M Romagnoli, P Godard, J Bousquet, P Chanez.   

Abstract

Inducing sputum using hypertonic saline is a noninvasive method to investigate airway inflammation in people with asthma. However, hypertonic saline may also induce bronchoconstriction in some patients. The aim of the study was to examine whether the overall safety of using hypertonic saline to induce sputum in patients with mild to moderate asthma could be extended to patients with severe and/or uncontrolled asthma. Nine control subjects and 64 asthmatic patients with varying severity of the disease (FEV1 40-126% predicted values) were studied. Twenty-one of those patients had uncontrolled asthma. Sputum was induced in a standardized manner using hypertonic saline. The safety of the procedure was evaluated by assessing the clinical response and measuring FEV1 just before and during sputum induction. The procedure was well tolerated in most patients, but it had to be stopped due to side effects in 11.6% of patients with severe asthma. None of the side reactions were severe. Few patients with uncontrolled (17.3%) or severe asthma (18.6%) had a drop in FEV1 of 10-20%. The fall in FEV1 was significantly greater in patients with severe asthma than those with mild disease (p < 0.02 Mann-Whitney U test). We conclude that hypertonic saline-induced sputum is a safe technique even in patients with severe asthma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9563729     DOI: 10.1164/ajrccm.157.4.9610008

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  7 in total

1.  Safety of sputum induction with hypertonic saline solution in exercise-induced bronchoconstriction.

Authors:  Chris Carlsten; Moira L Aitken; Teal S Hallstrand
Journal:  Chest       Date:  2007-05       Impact factor: 9.410

2.  Safety and tolerability of sputum induction in adolescents and adults with suspected pulmonary tuberculosis.

Authors:  H D Geldenhuys; W Kleynhans; N Buckerfield; M Tameris; Y Gonzalez; H Mahomed; G Hussey; W Hanekom; M Hatherill
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-28       Impact factor: 3.267

3.  The effect of Ginkgo Biloba extract on the expression of PKCalpha in the inflammatory cells and the level of IL-5 in induced sputum of asthmatic patients.

Authors:  Yijun Tang; Yongjian Xu; Shengdao Xiong; Wang Ni; Shixin Chen; Baoan Gao; Tao Ye; Yong Cao; Chunling Du
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-08

4.  Relationship between dendritic cells and activated eosinophils in induced sputum of asthmatics.

Authors:  Youngil I Koh; Jee-Bum Lee; Se-Ryeon Lee; Seung-Gyu Ji; Inseon-S Choi
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

5.  Dyspnea assessment and adverse events during sputum induction in COPD.

Authors:  Demosthenes Makris; Nikolaos Tzanakis; Joanna Moschandreas; Nikolaos M Siafakas
Journal:  BMC Pulm Med       Date:  2006-06-29       Impact factor: 3.317

6.  Eosinophil activation markers in induced sputum in asthmatics.

Authors:  A S Jang; I S Choi
Journal:  Korean J Intern Med       Date:  2000-01       Impact factor: 2.884

7.  Sputum analysis in diagnosis and management of obstructive airway diseases.

Authors:  Paige Lacy; Jennifer L Lee; Dilini Vethanayagam
Journal:  Ther Clin Risk Manag       Date:  2005-09       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.